Literature DB >> 27714761

A phase II trial of TBL-12 sea cucumber extract in patients with untreated asymptomatic myeloma.

Ajai Chari1, Amitabha Mazumder2, Kenneth Lau1, Donna Catamero1, Zachary Galitzeck1, Sundar Jagannath1.   

Abstract

Entities:  

Keywords:  cancer; myeloma; myeloma therapy; risk factors

Mesh：

Substances：

Year:  2016        PMID： 27714761     DOI： 10.1111/bjh.14314

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

Review 1.  Smoldering Multiple Myeloma: Emerging Concepts and Therapeutics.

Authors:  Srinath Sundararajan; Abhijeet Kumar; Neha Korde; Amit Agarwal
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

2.  Antiproliferative Activity, Proapoptotic Effect, and Cell Cycle Arrest in Human Cancer Cells of Some Marine Natural Product Extract.

Authors:  Hong Cui; Mansour A E Bashar; Islam Rady; Hussein A El-Naggar; Lamiaa M Abd El-Maoula; Ahmed B M Mehany
Journal:  Oxid Med Cell Longev       Date:  2020-11-25       Impact factor: 6.543

Review 3.  Culturable Microorganisms Associated with Sea Cucumbers and Microbial Natural Products.

Authors:  Lei Chen; Xiao-Yu Wang; Run-Ze Liu; Guang-Yu Wang
Journal:  Mar Drugs       Date:  2021-08-16       Impact factor: 5.118
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.